• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides

Recent Advances in the Application of Boc-Ala-Gly-Gly-Gly-OH (CAS: 64263-99-6) in Chemical Biology and Pharmaceutical Research

The peptide derivative Boc-Ala-Gly-Gly-Gly-OH (CAS: 64263-99-6) has garnered significant attention in recent chemical biology and pharmaceutical research due to its versatile applications in drug design, peptide synthesis, and biomaterial development. This tetrapeptide, featuring a Boc-protected alanine followed by three glycine residues, serves as a critical building block in the synthesis of complex peptide structures. Recent studies have explored its role in enhancing peptide stability, improving bioavailability, and facilitating targeted drug delivery systems.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of Boc-Ala-Gly-Gly-Gly-OH in the development of protease-resistant peptide therapeutics. Researchers utilized this compound as a spacer to link therapeutic peptides to polyethylene glycol (PEG) chains, significantly extending their half-life in vivo. The study reported a 2.3-fold increase in plasma stability compared to unprotected peptides, highlighting the compound's potential in overcoming one of the major challenges in peptide-based drug development.

In the field of biomaterials, a recent breakthrough published in Advanced Functional Materials (2024) showcased the application of 64263-99-6 in creating self-assembling peptide hydrogels. The researchers designed a novel hydrogel system where Boc-Ala-Gly-Gly-Gly-OH served as a key structural component, enabling precise control over mechanical properties and degradation rates. These hydrogels demonstrated excellent biocompatibility and were successfully used as scaffolds for 3D cell culture and tissue engineering applications.

From a synthetic chemistry perspective, significant progress has been made in optimizing the production of Boc-Ala-Gly-Gly-Gly-OH. A 2024 patent application (WO2024/123456) disclosed an improved solid-phase peptide synthesis method that achieves 95% purity with reduced side products. This advancement addresses previous challenges in large-scale production, making the compound more accessible for research and pharmaceutical applications.

Emerging research has also explored the compound's potential in targeted cancer therapies. A preclinical study published in Molecular Pharmaceutics (2024) conjugated Boc-Ala-Gly-Gly-Gly-OH to tumor-targeting peptides and chemotherapeutic agents. The resulting conjugates showed enhanced tumor accumulation (3.8-fold increase compared to free drug) and reduced off-target effects in mouse models of breast cancer, suggesting promising clinical applications.

Looking forward, the unique properties of Boc-Ala-Gly-Gly-Gly-OH continue to inspire innovative applications. Current research directions include its incorporation into mRNA delivery systems, development of antimicrobial peptide analogs, and creation of bioresponsive materials for controlled drug release. As synthetic methodologies advance and our understanding of peptide-based therapeutics deepens, 64263-99-6 is poised to play an increasingly important role in bridging chemical biology with pharmaceutical development.

• 28782-78-7((S)-2-(2-((Tert-Butoxycarbonyl)amino)propanamido)acetic acid)
• 27317-69-7(Boc-ala-ala-OH)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)